Human epidermal growth factor receptor 2(Her2)-targeted pH-responsive MR/NIRF bimodal imaging-mediated nano-delivery system for the diagnosis and treatment of undifferentiated thyroid cancer
Drug Delivery and Translational Research · 2025
DOI: 10.1007/s13346-024-01727-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Delivery and Translational Research, 2025. Verfasst von Qiushi Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar, 101006, China. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Sorafenib, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Natural Science Foundation of Heilongjiang Province, The Scientific Research Project of Heilongjiang Provincial Health and Wellness Commission.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar, 101006, China.
- Department of Molecular Imaging, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar, 101006, China.
- Department of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar, 101006, China. haoliguo@qmu.edu.cn.
- Department of Molecular Imaging, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar, 101006, China. m15946506063@163.com.
ORCID-Profile: Zhongyuan Li
Förderung
- Natural Science Foundation of Heilongjiang Province
- The Scientific Research Project of Heilongjiang Provincial Health and Wellness Commission
Zitieren
APA
Jia, Q., Li, F., Li, C., Guo, C., Wu, S., Hao, L., & Li, Z. (2025). Human epidermal growth factor receptor 2(Her2)-targeted pH-responsive MR/NIRF bimodal imaging-mediated nano-delivery system for the diagnosis and treatment of undifferentiated thyroid cancer. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01727-2
Vancouver
Jia Q, Li F, Li C, Guo C, Wu S, Hao L, et al. Human epidermal growth factor receptor 2(Her2)-targeted pH-responsive MR/NIRF bimodal imaging-mediated nano-delivery system for the diagnosis and treatment of undifferentiated thyroid cancer. Drug Delivery and Translational Research. 2025. doi:10.1007/s13346-024-01727-2
BibTeX
@article{Jia2025,
author = {Jia, Qiushi and Li, Fulin and Li, Chunxiang and Guo, Changzhi and Wu, Shuang and Hao, Liguo and Li, Zhongyuan},
title = {Human epidermal growth factor receptor 2(Her2)-targeted pH-responsive MR/NIRF bimodal imaging-mediated nano-delivery system for the diagnosis and treatment of undifferentiated thyroid cancer},
journal = {Drug Delivery and Translational Research},
year = {2025},
doi = {10.1007/s13346-024-01727-2}
}
EUVIMED